1. Acknowledgement to Referees

   Acknowledgement to Referees 19 November 2015 Pages: 1179 - 1182

2. Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children

   • Frederique Rodieux
   • Melanie Wilbaux
   • Marc Pfister

   Review Article Open access 03 July 2015 Pages: 1183 - 1204

   

3. Asunaprevir: A Review of Preclinical and Clinical Pharmacokinetics and Drug–Drug Interactions

   • Timothy Eley
   • Tushar Garimella
   • Richard J. Bertz

   Review Article 16 July 2015 Pages: 1205 - 1222

   

4. Therapeutic Drug Monitoring of Voriconazole in the Management of Invasive Fungal Infections: A Critical Review

   • Hazem Elewa
   • Eman El-Mekaty
   • Kyle John Wilby

   Review Article 13 June 2015 Pages: 1223 - 1235

5. Population Pharmacokinetics of Darbepoetin Alfa in Conjunction with Hypothermia for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy

   • Jessica K. Roberts
   • Chris Stockmann
   • Catherine M. T. Sherwin

   Original Research Article 20 May 2015 Pages: 1237 - 1244

   

6. A Prediction Model of Drug Exposure in Cirrhotic Patients According to Child–Pugh Classification

   • Julie Steelandt
   • Elodie Jean-Bart
   • Michel Tod

   Original Research Article 13 June 2015 Pages: 1245 - 1258

   

7. Genetics-Based Population Pharmacokinetics and Pharmacodynamics of Risperidone in a Psychiatric Cohort

   • Frederik Vandenberghe
   • Monia Guidi
   • Chin B. Eap

   Original Research Article 01 July 2015 Pages: 1259 - 1272

   

8. Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design

   • Stéphanie Leroux
   • Mark A. Turner
   • On behalf of the TINN (Treat Infections in NeoNates) and GRiP (Global Research in Paediatrics) Consortiums

   Original Research Article 11 June 2015 Pages: 1273 - 1285

   

9. Comment on Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design

   • Joseph F. Standing
   • Brian J. Anderson
   • Tuuli Metsvaht

   Letter to the Editor 07 November 2015 Pages: 1287 - 1288

   

10. Author’s Reply to Standing et al. Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design

    • Wei Zhao
    • Evelyne Jacqz-Aigrain

    Letter to the Editor 07 November 2015 Pages: 1289 - 1291

    

11. Comment on: “Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modelling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection”

    • Nuggehally R. Srinivas

    Letter to the Editor 20 October 2015 Pages: 1293 - 1295

    

12. Author’s Reply to Srinivas: “Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection”

    • Florence Namour

    Commentary Open access 20 October 2015 Pages: 1297 - 1298